Penumbra Inc PEN

Healthcare Medical Devices

Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.

NYSE:PEN - Post by User

Penumbra Inc

<< Previous

Bullboard Posts

Post by whytestockson Oct 31, 2024 3:47pm

25 Views

Post# 36291200

PEN Price Target Alert: $235.00. Issued by Piper Sandler

News; $PEN PEN Price Target Alert: $235.00. Issued by Piper Sandler2024-10-31 08:59:42 ET Matt O'Brien from Piper Sandler issued a price target of $235.00 for PEN on 2024-10-31 07:35:00. The adjusted price target was set to $235.00. At the time of the announcement, PEN was trading at $211.29. The overall price target consensus is at $22...PEN - PEN Price Target Alert: $235.00. Issued by Piper Sandler

<< Previous

Bullboard Posts

AI companies to invest in